Pfizer: Chronic Pain trials
The registry lists 17 Chronic Pain studies with Pfizer as lead sponsor. 0 are open to participants now and 10 have results posted.
Phase 1 9Phase 3 6Phase 4 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back PainCompletedNCT02725411Phase 3Results posted
- A Phase 3 Study of Tanezumab for Chronic Low Back PainCompletedNCT02528253Phase 3Results posted
- Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or KneeCompletedNCT02528188Phase 3Results posted
- A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and SnortedCompletedNCT01775189Phase 1Results posted
- A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid AbusersCompletedNCT01746901Phase 1Results posted
- A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back PainCompletedNCT01571362Phase 3Results posted
- Conversion to Embeda With Rescue TrialTerminatedNCT01179191Phase 4Results posted
- Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent PatientsTerminatedNCT01100437Phase 4Results posted
- A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or KneeCompletedNCT00420992Phase 3Results posted
- Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant PainCompletedNCT00415597Phase 3Results posted
- Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And PlaceboCompletedNCT01595867Phase 1
- A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy VolunteersCompletedNCT01530542Phase 1
- To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological ActivityCompletedNCT01165736Phase 1
- A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be InvestigatedCompletedNCT01165723Phase 1
- A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers.CompletedNCT01119235Phase 1
- To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both MedicationsCompletedNCT01103739Phase 1
- A Multiple Dose Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04457845 in Healthy VolunteersCompletedNCT00836082Phase 1